Do analysts rate PRPO or LFMD?

LifeMD has a consensus price target of $7.57, indicating a potential upside of 176.33%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70

Which has better earnings & valuation, PRPO or LFMD?

LifeMD has higher revenue and earnings than Precipio. LifeMD is trading at a lower price-to-earnings ratio than Precipio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Precipio $24.05M 1.72 -$360K -$0.64 N/A LifeMD $194.05M 0.68 $14.35M -$0.05 N/A

Is PRPO or LFMD more profitable?

LifeMD has a net margin of 0.10% compared to Precipio's net margin of -4.47%. Precipio's return on equity of -8.49% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets Precipio -4.47% -8.49% -5.75% LifeMD 0.10% -168.23% -31.27%

Do analysts recommend PRPO or JYNT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Joint 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Which has preferable valuation and earnings, PRPO or JYNT?

Joint has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Precipio $24.05M 1.72 -$360K -$0.64 N/A Joint $54.90M 1.88 $2.91M $0.27 26.96

Is PRPO or JYNT more profitable?

Joint has a net margin of 6.49% compared to Precipio's net margin of -4.47%. Joint's return on equity of 12.02% beat Precipio's return on equity. Company Net Margins Return on Equity Return on Assets Precipio -4.47% -8.49% -5.75% Joint 6.49% 12.02% 3.47%

Does the media refer more to PRPO or JYNT?

In the previous week, Joint had 1 more articles in the media than Precipio. MarketBeat recorded 2 mentions for Joint and 1 mentions for Precipio. Precipio's average media sentiment score of 0.75 beat Joint's score of 0.00 indicating that Precipio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precipio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Joint 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend PRPO or PARK?

Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 43.65%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts plainly believe Park Dental Partners is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Park Dental Partners 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has preferable earnings & valuation, PRPO or PARK?

Precipio is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Precipio $24.05M 1.72 -$360K -$0.64 N/A Park Dental Partners $244.49M 0.39 -$360K $1.05 18.90

Does the media prefer PRPO or PARK?

In the previous week, Park Dental Partners had 1 more articles in the media than Precipio. MarketBeat recorded 2 mentions for Park Dental Partners and 1 mentions for Precipio. Park Dental Partners' average media sentiment score of 1.47 beat Precipio's score of 0.75 indicating that Park Dental Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precipio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Park Dental Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PIII or PRPO?

P3 Health Partners currently has a consensus price target of $17.00, suggesting a potential upside of 167.30%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate PRPO or ACH?

Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 197.38%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Does the media refer more to PRPO or ACH?

In the previous week, Precipio and Precipio both had 1 articles in the media. Accendra Health's average media sentiment score of 0.90 beat Precipio's score of 0.75 indicating that Accendra Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precipio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accendra Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Precipio (PRPO) Competitors

$23.13 +0.40 (+1.76%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$23.30 +0.17 (+0.73%)

As of 10/2/2026 07:30 PM Eastern

Compare

PRPO vs. LFMD, JYNT, PARK, PIII, and ACH

Should you buy Precipio stock or one of its competitors? Precipio's main competitors and comparable companies include LifeMD (LFMD), Joint (JYNT), Park Dental Partners (PARK), P3 Health Partners (PIII), and Accendra Health (ACH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Precipio compare to LifeMD?

Precipio (NASDAQ:PRPO) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

LifeMD has a net margin of 0.10% compared to Precipio's net margin of -4.47%. Precipio's return on equity of -8.49% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
LifeMD	0.10%	-168.23%	-31.27%

LifeMD has a consensus price target of $7.57, indicating a potential upside of 176.33%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

LifeMD has higher revenue and earnings than Precipio. LifeMD is trading at a lower price-to-earnings ratio than Precipio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.72	-$360K	-$0.64	N/A
LifeMD	$194.05M	0.68	$14.35M	-$0.05	N/A

10.5% of Precipio shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 16.6% of Precipio shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Precipio has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, LifeMD has a beta of 1.99, meaning that its stock price is 99% more volatile than the broader market.

In the previous week, Precipio had 1 more articles in the media than LifeMD. MarketBeat recorded 1 mentions for Precipio and 0 mentions for LifeMD. Precipio's average media sentiment score of 0.75 beat LifeMD's score of 0.00 indicating that Precipio is being referred to more favorably in the media.

Company	Overall Sentiment
Precipio	Positive
LifeMD	Neutral

Summary

LifeMD beats Precipio on 10 of the 16 factors compared between the two stocks.

How does Precipio compare to Joint?

Precipio (NASDAQ:PRPO) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

10.5% of Precipio shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 16.6% of Precipio shares are held by insiders. Comparatively, 30.2% of Joint shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Joint had 1 more articles in the media than Precipio. MarketBeat recorded 2 mentions for Joint and 1 mentions for Precipio. Precipio's average media sentiment score of 0.75 beat Joint's score of 0.00 indicating that Precipio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precipio	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Joint	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Precipio has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, Joint has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market.

Joint has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.72	-$360K	-$0.64	N/A
Joint	$54.90M	1.88	$2.91M	$0.27	26.96

Joint has a net margin of 6.49% compared to Precipio's net margin of -4.47%. Joint's return on equity of 12.02% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
Joint	6.49%	12.02%	3.47%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Joint	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

Joint beats Precipio on 12 of the 14 factors compared between the two stocks.

How does Precipio compare to Park Dental Partners?

Precipio (NASDAQ:PRPO) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Park Dental Partners has a net margin of 0.00% compared to Precipio's net margin of -4.47%. Park Dental Partners' return on equity of 0.00% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
Park Dental Partners	N/A	N/A	N/A

Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 43.65%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts plainly believe Park Dental Partners is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Precipio is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.72	-$360K	-$0.64	N/A
Park Dental Partners	$244.49M	0.39	-$360K	$1.05	18.90

10.5% of Precipio shares are owned by institutional investors. 16.6% of Precipio shares are owned by insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Park Dental Partners had 1 more articles in the media than Precipio. MarketBeat recorded 2 mentions for Park Dental Partners and 1 mentions for Precipio. Park Dental Partners' average media sentiment score of 1.47 beat Precipio's score of 0.75 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precipio	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Park Dental Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Park Dental Partners beats Precipio on 12 of the 15 factors compared between the two stocks.

How does Precipio compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and Precipio (NASDAQ:PRPO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Precipio has a net margin of -4.47% compared to P3 Health Partners' net margin of -6.55%. P3 Health Partners' return on equity of 0.00% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-6.55%	N/A	-16.40%
Precipio	-4.47%	-8.49%	-5.75%

Precipio has lower revenue, but higher earnings than P3 Health Partners. Precipio is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.03	-$147.95M	-$33.00	N/A
Precipio	$24.05M	1.72	-$360K	-$0.64	N/A

7.8% of P3 Health Partners shares are owned by institutional investors. Comparatively, 10.5% of Precipio shares are owned by institutional investors. 10.9% of P3 Health Partners shares are owned by insiders. Comparatively, 16.6% of Precipio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Precipio had 1 more articles in the media than P3 Health Partners. MarketBeat recorded 1 mentions for Precipio and 0 mentions for P3 Health Partners. Precipio's average media sentiment score of 0.75 beat P3 Health Partners' score of 0.00 indicating that Precipio is being referred to more favorably in the news media.

Company	Overall Sentiment
P3 Health Partners	Neutral
Precipio	Positive

P3 Health Partners currently has a consensus price target of $17.00, suggesting a potential upside of 167.30%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

P3 Health Partners has a beta of 1.7, suggesting that its stock price is 70% more volatile than the broader market. Comparatively, Precipio has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

Summary

Precipio beats P3 Health Partners on 9 of the 16 factors compared between the two stocks.

How does Precipio compare to Accendra Health?

Precipio (NASDAQ:PRPO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

Precipio has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 197.38%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Precipio has higher earnings, but lower revenue than Accendra Health. Precipio is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.72	-$360K	-$0.64	N/A
Accendra Health	$2.73B	0.01	-$1.10B	-$3.91	N/A

10.5% of Precipio shares are held by institutional investors. 16.6% of Precipio shares are held by company insiders. Comparatively, 2.3% of Accendra Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Precipio has a net margin of -4.47% compared to Accendra Health's net margin of -11.41%. Accendra Health's return on equity of -4.02% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
Accendra Health	-11.41%	-4.02%	0.70%

In the previous week, Precipio and Precipio both had 1 articles in the media. Accendra Health's average media sentiment score of 0.90 beat Precipio's score of 0.75 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Precipio	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accendra Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Accendra Health beats Precipio on 8 of the 14 factors compared between the two stocks.

Get Precipio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRPO vs. The Competition

Export

Metric	Precipio	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$40.69M	$9.59B	$7.14B	$13.18B
Dividend Yield	N/A	2.61%	2.53%	16.78%
P/E Ratio	-36.14	34.21	275.97	26.04
Price / Sales	1.72	5.44	669.23	109.59
Price / Cash	28.61	120.59	77.60	51.75
Price / Book	2.78	5.15	10.93	6.31
Net Income	-$360K	$315.68M	$3.51B	$362.16M
7 Day Performance	-2.20%	-2.59%	-2.00%	-1.66%
1 Month Performance	-11.45%	-3.19%	-6.15%	-4.50%
1 Year Performance	9.88%	7.93%	7.44%	2.06%

Precipio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRPO Precipio	0.4376 of 5 stars	$23.13 +1.8%	N/A	+10.9%	$40.69M	$24.05M	N/A	71
LFMD LifeMD	3.1788 of 5 stars	$2.91 +0.9%	$7.57 +160.6%	-60.4%	$140.02M	$191.59M	N/A	384	News Coverage
JYNT Joint	1.4365 of 5 stars	$7.41 -4.4%	N/A	-21.7%	$104.76M	$54.90M	27.44	330
PARK Park Dental Partners	4.1016 of 5 stars	$20.56 +0.3%	$28.50 +38.6%	N/A	$97.87M	$244.49M	19.58	1,212	News Coverage Short Interest Increase
PIII P3 Health Partners	1.9984 of 5 stars	$6.66 +1.9%	$17.00 +155.2%	-26.1%	$48.37M	$1.50B	N/A	320	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRPO) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Precipio (PRPO) Competitors

PRPO vs. LFMD, JYNT, PARK, PIII, and ACH

How does Precipio compare to LifeMD?

Summary

How does Precipio compare to Joint?

Summary

How does Precipio compare to Park Dental Partners?

Summary

How does Precipio compare to P3 Health Partners?

Summary

How does Precipio compare to Accendra Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRPO vs. The Competition

Precipio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Precipio (PRPO) Competitors

PRPO vs. LFMD, JYNT, PARK, PIII, and ACH

How does Precipio compare to LifeMD?

Is PRPO or LFMD more profitable?

Do analysts rate PRPO or LFMD?

Which has better earnings & valuation, PRPO or LFMD?

Do institutionals & insiders believe in PRPO or LFMD?

Which has more volatility & risk, PRPO or LFMD?

Does the media refer more to PRPO or LFMD?

Summary

How does Precipio compare to Joint?

Do institutionals and insiders hold more shares of PRPO or JYNT?

Does the media refer more to PRPO or JYNT?

Which has more volatility & risk, PRPO or JYNT?

Which has preferable valuation and earnings, PRPO or JYNT?

Is PRPO or JYNT more profitable?

Do analysts recommend PRPO or JYNT?

Summary

How does Precipio compare to Park Dental Partners?

Is PRPO or PARK more profitable?

Do analysts recommend PRPO or PARK?

Which has preferable earnings & valuation, PRPO or PARK?

Do insiders and institutionals believe in PRPO or PARK?

Does the media prefer PRPO or PARK?

Summary

How does Precipio compare to P3 Health Partners?

Is PIII or PRPO more profitable?

Which has stronger earnings & valuation, PIII or PRPO?

Do institutionals & insiders have more ownership in PIII or PRPO?

Does the media prefer PIII or PRPO?

Do analysts recommend PIII or PRPO?

Which has more volatility and risk, PIII or PRPO?

Summary

How does Precipio compare to Accendra Health?

Which has more volatility and risk, PRPO or ACH?

Do analysts rate PRPO or ACH?

Which has preferable earnings and valuation, PRPO or ACH?

Do institutionals and insiders believe in PRPO or ACH?

Is PRPO or ACH more profitable?

Does the media refer more to PRPO or ACH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRPO vs. The Competition

Precipio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools